<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Upper endoscopy is commonly used in the diagnosis and management of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Evidence demonstrates that it is indicated only in certain situations, and inappropriate use generates unnecessary costs and exposes patients to harms without improving outcomes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The Clinical Guidelines Committee of the American College of Physicians reviewed evidence regarding the indications for, and yield of, upper endoscopy in the setting of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, and to highlight how clinicians can increase the delivery of high-value health care </plain></SENT>
<SENT sid="3" pm="."><plain>BEST PRACTICE ADVICE 1: Upper endoscopy is indicated in men and women with heartburn and alarm symptoms (<z:hpo ids='HP_0002015'>dysphagia</z:hpo>, <z:mp ids='MP_0001914'>bleeding</z:mp>, <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0001824'>weight loss</z:hpo>, and recurrent <z:hpo ids='HP_0002013'>vomiting</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>BEST PRACTICE ADVICE 2: Upper endoscopy is indicated in men and women with: Typical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms that persist despite a therapeutic trial of 4 to 8 weeks of twice-daily <z:chebi fb="0" ids="49200">proton-pump inhibitor</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Severe erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> after a 2-month course of <z:chebi fb="0" ids="49200">proton-pump inhibitor</z:chebi> therapy to assess healing and rule out <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Recurrent endoscopy after this follow-up examination is not indicated in the absence of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>History of <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo> who have recurrent symptoms of <z:hpo ids='HP_0002015'>dysphagia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>BEST PRACTICE ADVICE 3: Upper endoscopy may be indicated: In men older than 50 years with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms (symptoms for more than 5 years) and additional risk factors (nocturnal reflux symptoms, <z:hpo ids='HP_0002036'>hiatal hernia</z:hpo>, elevated body mass index, tobacco use, and intra-abdominal distribution of fat) to detect esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>For surveillance evaluation in men and women with a history of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In men and women with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and no <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, surveillance examinations should occur at intervals no more frequently than 3 to 5 years </plain></SENT>
<SENT sid="11" pm="."><plain>More frequent intervals are indicated in patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>